Drugs / Synatura®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03623282 | Apr 2017 → May 2018 | chronic obstructive pulmonary disease | Ahn-Gook Pharmaceuticals Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Synatura | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03623282 ↗ |